Explore Oncology Resources | PP-PF-ONC-GB-0411, February 2024

Oncology

mCRC Resources

STIVARGA® (regorafenib)

PP-STI-GB-0199, February 2024

NUBEQA®▼ (darolutamide) Resources

PP-NUB-GB-1312, February 2024

HCC Resources

Nexavar® (sorafenib) | Stivarga® (regorafenib)

PP-NEX-GB-0215, February 2024

Xofigo®▼ (radium-223 dichloride) Resources

PP-XOF-GB-0516, February 2024

nmCRPC Patient Case Study

A Clinical Nurse Specialist Perspective - NUBEQA®▼ (darolutamide)

PP-NUB-GB-1331, February 2024

nmCRPC Patient Case Study

A Urologist Perspective - NUBEQA®▼ (darolutamide)

PP-NUB-GB-1330, February 2024

nmCRPC Patient Case Study

An Oncologist Perspective - NUBEQA®▼ (darolutamide)

PP-NUB-GB-1328, February 2024

nmCRPC Patient Case Study

A Pharmacist Perspective - NUBEQA®▼ (darolutamide)

PP-NUB-GB-1329, February 2024